LGBS, IDVC, GENE are included in our Midday Stock Report

Posted on 7/26/2012 12:40:48 PM in #Stocks | 0 comments comments

Legends Business
Group (PINK:LGBS) reached
up 72.97% in morning trading to $.0064 with 13M shares traded. Legends Business
Group, Inc. was incorporated in March 2006.Currently the company’s newly
launched division, Legends Power, has focused its mission to look for, test and
acquire alternative and exotic energy products and technology and bring them
into the marketplace. Legends Business Group (LGBS:PK) Tuesday announce that it
has retained Patrick Rodgers, CPA, PA based in Florida, as its' auditor.
"Legends is proud to have taken its first step to become a fully reporting
Bulletin Board Company by retaining Patrick Rodgers, CPA, PA to perform the
upcoming audit required to meet any reporting needs with the Securities and
Exchange Commission ("SEC")," said Rudy Sablon, LGBS's President
and CEO.

Infrastructure
Developments Corp. (OTCBB:IDVC) reached up 38.89% in morning trading
to $.0025 with 7M shares traded. Infrastructure Developments Corporation
conducts its business through our subsidiary Interspec International, which is
headquartered in the United States and focuses on project management in the
Middle East, East Asia, and Oceania. Interspec fills an underserved niche in
the global project spectrum, targeting specialized projects and subcontracts
that are too small to attract the attention of the giant multinational firms
but which still require world class engineering expertise. Interspec’s managers
have decades of engineering experience, not only in the boardroom but in the
hands-on world of managing complex engineering enterprises in difficult
political environments and high-threat situations. Infrastructure Developments
Corp. (IDVC) announced today that the Company pre-paid in full an outstanding
$19,000 convertible note.

Genetic Technologies
Limited (Nasdaq:GENE) reached up 16.74% in
morning trading to $4.086 with 900K shares traded. Genetic Technologies is an
established diagnostics company with more than 20 years of experience in
commercializing genetic testing, non-coding DNA and product patenting. Genetic
Technologies is focused on the commercialization of its patent portfolio
through an active out-licensing program and the global expansion of its
oncology and cancer management diagnostics assets. Its U.S. subsidiary,
Phenogen Sciences, offers novel predictive testing and assessment tools to help
physicians proactively manage women's health. Phenogen's lead product,
BREVAGen™, is a first in class, clinically validated risk assessment test for
non-familial breast cancer. Genetic Technologies Limited (GENE) announced that
the Laboratory Field Services Unit of the California Department of Public
Health (CDPH) has granted a license to the Company's Australian-based
laboratory. BREVAGen™ may now be offered for sale into the State of California.

For
a detailed quote on any of the following companies, or to read the full news
articles visit PennyTrader.com

About PennyTrader.com

PennyTrader.com is a financial and investor relations website committed to
covering the microcap market space including Pink Sheets and OTC Bulletin Board
and sub-$5 big board stocks. We strive to provide you with the best stocks
alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board
stocks, and timely stocks picks and alerts. Our goal is to inform you of the
HOTTEST stocks in the market before they move. Our staff has years experience
in the stock market, and we are confident that you’ll be impressed with the
results of our stock picks! If you wish to feature your organization on our
website then you can contact us at publisher@pennytrader.com.

Disclosure:
PennyTrader.com is not currently being compensated for any stocks covered in
this midday report.

PennyTrader.com is not a registered investment advisers
or broker/dealer. PennyTrader.com makes no recommendation that the purchase of
securities of companies profiled in this press release is suitable or advisable
for any person or that an investment such securities will be profitable. In
general, given the nature of the micro cap companies covered and the potential
lack of an active trading market their securities, investing in such securities
is highly speculative and carries a high degree of risk. For our full
disclaimer go to CLICK
HERE